Long-term Seroprotection Rates Following Second Dose of Measles as MMR Vaccine at 15 months in Indian Children-Reference-Cited by-同舟云学术

Long-term Seroprotection Rates Following Second Dose of Measles as MMR Vaccine at 15 months in Indian Children

Published:2018-02-09 Issue:5 Volume:55 Page:405-407
ISSN:0019-6061
Container-title:Indian Pediatrics
language:en
Short-container-title:Indian Pediatr

Author:

Hansashree P.,Verma Sanjay,Rawat Amit,Sankhyan Naveen,Bharti Bhavneet

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/article/10.1007/s13312-018-1282-8/fulltext.html

Reference15 articles.

1. John TJ. The role of Indian Academy of Pediatrics in the Expanded Program of Immunization. Indian Pediatr. 1985;22:91–5.

2. Thapa A, Khanal S, Sharapov U, Swezy V, Sedai T, Dabbagh A, et al. Progress towards measles elimination-South-East Asia Region 2003-2013. MMWR Morb Mortal Wkly Rep. 2015;64:613–7.

3. WHO. Measles Vaccine: WHO position Paper. Wkly Epidemiol Rec.2009; 35: 84: 349-60.

4. Vashishtha VM, Yewale VN, Bansal CP, Mehta P. IAP perspectives on Measles and Rubella Elimination Strategies. Indian Pediatr. 2014;51:719–22.

5. Vashishtha VM, Choudhury P, Kalra A, Bose A, Thacker N, Yewale VN, et al. Indian Academy of Pediatrics (IAP) Recommended Immunization Schedule for children aged 0 through 18 years–India, 2014 and updates on Immunization. Indian Pediatr. 2014; 51: 785–800.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interplay of missed opportunity for vaccination and poor response to the vaccine led to measles outbreak in a slum area of Eastern Mumbai, India;Epidemiology and Infection;2024

2. A phase II/III randomised, comparative study evaluating the safety and immunogenicity of Biological E's live, attenuated Measles-Rubella vaccine in 9–12 month old healthy infants;Contemporary Clinical Trials Communications;2023-12

3. Immunogenicity of measles-rubella vaccine administered under India's Universal Immunization Programme in the context of measles–rubella elimination goal: A longitudinal study;Indian Journal of Medical Research;2023

4. Seroprotection against measles in previously vaccinated children with difficult-to-treat nephrotic syndrome;Pediatric Nephrology;2021-09-25

5. Measles Specific Immunoglobulin G Response in Children Aged 4–12 Year Who Received Two Doses of Measles Containing Vaccine in Infancy;Indian Pediatrics;2021-03